Deep Cultivation and Continuous Innovation: BD China Pioneers a New Era of Intelligent Bioscience

Hefei, China, November 5, 2016-- The 11th NationalImmunologyAt the academic conference, BD China grandly announced the latest cell sorter, the BD FACSMelody^TMBD Systems and the BD Research Reagents Online Store Officially Launch. This marks China’s first zero-barrier entry flow cytometry cell sorter and a research reagents marketplace offering comprehensive scientific research services. These two groundbreaking initiatives signify that BD China is leading the life sciences into a new era of intelligence.

This further demonstrates BD’s deep roots in China, its unwavering commitment to providing innovative technologies and world-class, high-performance instruments, its dedication to aligning China’s flow cytometry capabilities with international standards, and its leadership in advancing global health.
 
Breakthrough Zero-to-Proficiency Intelligent Operation Makes Scientific Research Easier

“Fully automated design enables even novices with zero flow cytometry experience to master cell sorting within 2 hours” describes the newly launched BD FACSMelody.^TMThe biggest highlight. It completely ends the history of high operational barriers for flow cytometry cell sorters. Previously, training for operators of cell sorters took at least 5 days.

"As a leader in the cell analysis industry, BD is committed to advancing scientific research by providing researchers with high-quality, high-performance cell analysis and sorting tools. Since entering the Chinese market in 1994, we have continuously trained countless professionals in flow cytometry, supporting the sustainable development of China's biotechnology sector," said Mr. Lv Wen, Director of Biosciences for BD Greater China.

Although flow cytometric cell sorting has become the most advanced technique for quantitative cell analysis, the various models of flow cytometers previously launched on the market have set a "high threshold" for researchers.

“Flow cytometers with greater performance breakthroughs and more streamlined workflows are exactly what researchers desire.” Professor Yin Zhinan, Dean of the Institute of Biomedical Translation at Jinan University, stated, “Such intelligent devices will see broader applications across more fields.”

Researcher Zhang Xiaoming from the Pasteur Institute of the Chinese Academy of Sciences stated that the extensive time previously required to train operators of large-scale flow cytometric sorters, along with the need for dedicated personnel to operate the instruments, has long been a bottleneck in the application of flow cytometric cell sorting. The intelligent BD FACSMelody^TMThe introduction of flow cytometric cell sorters will significantly improve this issue.

“If a cell sorter can eliminate the need for complex instrument calibration, researchers can devote more time to the experiments and data analysis themselves, and such intelligent machines will have broader application prospects,” said Professor Qi Hai of Tsinghua University.

In fact, in the field of flow cytometry, BD China has been committed to substantial innovation and optimization, promoting the BD Flow Cytometry Academy across various regions to help cultivate professional personnel in flow cytometry technology in China. By continuously enhancing its R&D and innovation capabilities, BD provides researchers with a more efficient and convenient user experience while comprehensively improving overall user satisfaction. "We look forward to FACSMelody^TMCan be like BD's Accuri released five years ago^TM“The C6 personal flow cytometer ushered in a new era, becoming accessible to every ordinary laboratory in China due to its ease of use and simple operation,” said Zhang Lei, Market Manager for Biosciences at BD China.
 
Comprehensive Service Platform: The Internet Makes Scientific Research More Flexible

In the Innovation 3.0 era, people’s reliance on the Internet is growing ever stronger. The broad platform built upon the “Internet Plus” concept facilitates deep integration between the Internet and traditional industries, creating a new development ecosystem.

The newly launched BD Scientific Reagents Online Store represents a comprehensive innovation in the "Internet Plus" era. As a novel operational model, the store offers extensive product information, experimental data, and applications, along with color-matching tools to help users conveniently determine experimental protocols. The payment process retains the original offline model—order first, pay later—to maximally accommodate and support the daily workflows of researchers. Meanwhile, researchers can check inventory levels and estimated delivery times for required products via the client platform, allowing them to adjust experimental schedules accordingly. By adopting direct warehouse shipping, the online store has reduced the previous delivery lead time of approximately one week for in-stock items to around three days. Through this digital platform, researchers will enjoy the most convenient and efficient one-stop purchasing experience, significantly enhancing their work efficiency.

Dr. Bao Yan, Director of the Center for Translational Medicine at Changzheng Hospital Affiliated to the Second Military Medical University, stated that for frontline researchers, purchasing scientific reagents online represents a breakthrough. It allows them to check real-time inventory and place orders anytime and anywhere, while reducing delivery times by more than three days. This enables researchers to manage experimental processes more rationally and effectively, thereby significantly enhancing experimental efficiency.

“In the future, the BD Research Reagents Online Store will strive to become a comprehensive e-service platform in the field of biological sciences. It will not be limited to product purchases but will also provide any literature data and related training services and support needed by researchers, delivering full-spectrum services to customers in China’s life sciences sector and fulfilling BD’s long-standing commitment to China,” said Mr. Lv Wen, Director of Biosciences for Greater China at BD.

About BD

BD is a global medical technology company that improves methods of medical discovery, healthcareDiagnosisOutcomes and care quality to lead global health. BD is recognized across the industry for safeguarding the safety of patients and healthcare workers, as well as strengthening medical research and clinical laboratory development. The company provides innovative solutions to help advance cytology andGenomicsResearch and Strengthening of Infectious Diseases and CancerDiagnosis, improve medication management, promote infection prevention, provide tools for surgical and interventional procedures, optimize respiratory therapy, and supportDiabetesManagement. BD collaborates with institutions and organizations worldwide to address the most challenging global health issues. With a presence in over 50 countries and more than 45,000 employees, the company works closely with customers and partners to help improve healthcare outcomes, reduce healthcare costs, enhance efficiency, protect the safety of patients and healthcare workers, and increase access to care. As a business segment of BD, BD Biosciences is a global leader in the life sciences field, dedicated to providing innovative research and clinical tools to life science researchers and clinicians.
 
For more information, please visit:
BD China:www.bd.com/China 
BD Biosciences:http://m.bdbiosciences.com/cn/
BD Research Reagents Online Store:http://m.bdbiosciences.com/cn/go/ecommercelogin
（BioonBioon.com）

Recommended Related Conferences

2016 Summit on Innovation in Medical New Materials and Implantable Repair Technologies

Meeting Time:2016.12.15-12.16     Venue:Shanghai

Conference Details: http://www.bioon.com/z/2016mednm/